Science Explorer Back to mapMap
Discussion
Researcher · Juntendo University · Japan

Ken Tajima

Ken Tajima publishes mostly in Pulmonary and Respiratory Medicine, Molecular Biology and Oncology, on topics such as Lung Cancer Treatments and Mutations, Cancer Cells and Metastasis and Lung Cancer Research Studies.

ORCID 0000-0003-1688-0287 OpenAlex
World rank
#1,916,115
of 7,710,434 ranked researchers
Rank in Japan
#34,091
of 383,136
Works
77
Citations
1.5k
Citations per work
19.7
h-index
21
i10-index 34Top 18% in Pulmonary and Respiratory Medicine
Ken Tajima

What does Ken Tajima research?

Ken Tajima's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (24%).

Health Sciences: 40 works · 51.6% of their workMedicine: 40 works · 51.6% of their workPulmonary and Respiratory Medicine: 19 works · 24.5% of their workOncology: 13 works · 17.0% of their workRheumatology: 4 works · 5.7% of their workEpidemiology: 3 works · 4.4% of their workEverything else: 19 works · 24.5% of their workLife Sciences: 18 works · 23.9% of their workBiochemistry, Genetics and Molecular Biology: 18 works · 23.9% of their workMolecular Biology: 15 works · 18.9% of their workCancer Research: 4 works · 5.0% of their workTHEIR WORKKen Tajima77works
Life Sciences24%Health Sciences52%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4051.6%
  2. Everything else1924.5%
    1. Biochemistry, Genetics and Molecular Biology1823.9%
  1. 1Pulmonary and Respiratory Medicine24% of their works
  2. 2Molecular Biology19% of their works
  3. 3Oncology17% of their works
  4. 4Rheumatology6% of their works
  5. 5Cancer Research5% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Ken Tajima's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Epithelial-Mesenchymal Transition, Tumor Metastasis, Immunotherapy and Cancer Stem Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Clinical Trials222 topics
  2. Targeted Therapy222 topics
  3. ALK Inhibitors151 topic
  4. EGFR Mutations151 topic
  5. Epithelial-Mesenchymal Transition152 topics
  6. Tumor Metastasis152 topics
  7. Immunotherapy122 topics
  8. Cancer Stem Cells81 topic
  9. Stem Cell Niches81 topic
  10. Biomineralization71 topic
  11. Fibrosis71 topic
  12. Genomic Profiles71 topic
  13. Idiopathic Pulmonary Fibrosis71 topic
  14. Osteopontin71 topic
  15. Small-Cell Lung Cancer71 topic
  16. DNA Methylation61 topic
  17. Histone Modification61 topic
  18. Arginine Methylation51 topic
  19. BAP1 mutations51 topic
  20. Malignant Pleural Mesothelioma51 topic
  21. Protein Arginine Methyltransferases51 topic

Where does Ken Tajima work?

Ken Tajima's main affiliation in the publication record is Juntendo University, Japan.

How many publications and citations does Ken Tajima have?

OpenAlex counts 77 works and 1,515 citations for Ken Tajima, an h-index of 21, ranking #1,916,115 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ken Tajima. Posts are plain text and can be reported.